Tenon Medical, Inc TNONW

Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.28M, +126.8% YoY · Filed Aug 13, 2026

Tenon Medical, Inc (TNON) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.3 million and a net loss of $4.0 million. Free cash flow was -$2.9 million. As of Jun 30, 2026 it held $1.7 million in cash and investments and $1.3 million in total debt.

Revenue
$1.28M
+126.8% vs year-ago quarter
Net income
$-4.05M
-46.3% vs year-ago quarter
Operating cash flow
$-2.76M
-24.6% vs year-ago quarter
Free cash flow
$-2.93M
-28.1% vs year-ago quarter
EPS
$-12.35
+3.2% vs year-ago quarter
Dividend per share
None
Shares outstanding
667,047
-92.5% vs year-ago quarter
Net cash
$331,000
Q2 FY2026
Operating margin
-242.7%
TTM

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TNON (Nasdaq), TNONW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Los Gatos, CA
SEC filer status
, Emerging growth company
SEC CIK
1560293

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$1.3M
$1.4M
$1.5M
$1.2M
$564,000
Operating income
-$3.4M
-$3.3M
-$2.9M
-$3.4M
-$2.9M
Net income
-$4.0M
-$3.5M
-$2.8M
-$3.3M
-$2.8M
Diluted EPS
-$12.35
$0.31
-$290.22
-$0.40
-$12.76
Operating cash flow
-$2.8M
-$3.0M
-$2.2M
-$3.8M
-$2.2M
Free cash flow
-$2.9M
-$3.0M
-$2.4M
-$3.9M
-$2.3M
Total assets
$9.9M
$12.8M
$10.8M
$10.4M
$11.1M
Total liabilities
$11.7M
$10.9M
$5.7M
$5.6M
$4.4M
Stockholders' equity
-$1.7M
$1.9M
$5.0M
$4.8M
$6.7M
Cash and investments
$1.7M
$4.6M
$3.8M
$3.4M
$7.8M
Total debt
$1.3M
$1.4M
$141,000
$216,000
$290,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 22, 2026 Oct 16, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 16, 2026 Sep 11, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 31, 2026 Aug 27, 2026
8-K/A Amended current report
Material agreement, Unregistered share sale, Other events
Aug 26, 2026 Mar 11, 2026
8-K Current report
Other events
Aug 24, 2026 Aug 24, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.